GSK

GSK wins U.S. nod for two-drug HIV combination
Yahoo/Reuters
Tue, 04/9/19 - 08:25 am
GSK
FDA
HIV
Dovato
The top 15 pharma companies by 2018 revenue
Fierce Pharma
Mon, 04/8/19 - 11:30 pm
JNJ
Roche
Pfizer
Novartis
Merck
GSK
Sanofi
AbbVie
Bayer
Eli Lilly
Amgen
Bristol-Myers Squibb
Gilead Sciences
Teva Pharmaceutical
AstraZeneca
GSK adds to COPD pipeline as Exscientia deal bears fruit
Pharmaforum
Fri, 04/5/19 - 10:31 am
GSK
COPD
Exscientia
artificial intelligence
R&D
U.S., China key to GSK's consumer venture with Pfizer
Yahoo/Reuters
Thu, 04/4/19 - 12:06 pm
China
GSK
Pfizer
consumer healthcare
Go or no go? Abbvie, Glaxo and Heron await FDA verdicts
EP Vantage
Thu, 03/28/19 - 10:18 am
FDA
AbbVie
Heron Therapeutics
HTX-011
GSK
dolutegravir/lamivudine
risankizumab
Gimoti
Evoke Pharma
GSK mulls filings for multiple myeloma drug
Pharmaforum
Fri, 03/22/19 - 10:06 am
GSK
GSK2857916
antibody-drug conjugate
Multiple Myeloma
Will GSK/Tesaro’s Checkpoint Inhibitor Be Able to Compete With Merck’s Keytruda?
BioSpace
Wed, 03/20/19 - 12:27 pm
GSK
Tesaro
Merck
Keytruda
endometrial cancer
dostarlimab
Emma Walmsley earns £1M pay rise in her first full year at GSK's helm — but £5.9M package still trails other Big Pharma CEOs
Endpoints
Wed, 03/13/19 - 10:23 am
GSK
Emma Walmsley
Pharma CEOs
executive pay
Mylan's Advair generic pressures GSK with strong launch
BioPharma Dive
Fri, 03/8/19 - 04:09 pm
GSK
Mylan
generics
Advair
Wixela Inhub
Top 10 drugs losing exclusivity in 2019
Fierce Pharma
Tue, 03/5/19 - 09:40 am
market exclusivity
patents
Rituxan
Lyrica
Herceptin
Avastin
Epclusa
Harvoni
Pfizer
Roche
Gilead Sciences
Amgen
GSK
Allergan
Individor
Mylan launches Advair generic at 70% discount in US
Pharmaforum
Wed, 02/13/19 - 10:13 am
Mylan
GSK
Advair
generics
Pharma companies clear the R&D decks in Q4
Pharmaforum
Mon, 02/11/19 - 12:20 pm
R&D
GSK
Sanofi
Eli Lilly
Roche
Gilead Sciences
Artificial Intelligence Gaining Ground in Drug Development
BioSpace
Mon, 02/11/19 - 10:00 am
CASP
machine learning
artificial intelligence
drug development
Merck
Takeda
Atomwise
Bayer
GSK
Google DeepMind
Recursion Pharmaceuticals
Glaxo (GSK) Beats on Q4 Earnings, to Focus on Oncology in '19
Yahoo/Zacks.com
Thu, 02/7/19 - 09:44 am
GSK
earnings
Amid R&D rejigs, GlaxoSmithKline axes 6 pipeline assets
Fierce Biotech
Wed, 02/6/19 - 09:50 am
GSK
R&D
Sales of shingles vaccine boost profits at GSK
Yahoo/Reuters
Wed, 02/6/19 - 09:44 am
GSK
earnings
vaccines
shingles
Shingrix
Mylan’s Generic Advair Breathes New Life into Asthma Market
Xtalks
Tue, 02/5/19 - 10:03 am
Mylan
GSK
Advair
generics
FDA
asthma
Wixela Inhub
After Tesaro buy, GSK wades deeper into cancer unveiling big immunotherapy deal with Germany's Merck
Endpoints
Tue, 02/5/19 - 09:52 am
GSK
Merck KGaA
Tesaro
immunotherapy
Mylan finally crosses the finish line with long-awaited generic of GlaxoSmithKline's Advair
Fierce Pharma
Wed, 01/30/19 - 06:58 pm
Mylan
GSK
FDA
Advair
generics
Wixela Inhub
CEO Emma Walmsley takes GlaxoSmithKline on a quest for identity
Stat
Mon, 01/28/19 - 10:08 am
GSK
Pharma CEOs
Emma Walmsley

Pages